Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Osteopontin (OPN) is a multifunctional, extracellular structural protein involved in bone remodeling, immune regulation, and various disease processes, including cancer and inflammation. It interacts with integrins and CD44 receptors, mediating cell adhesion, migration, and signaling.
Blocking OPN interactions with integrins or CD44; inhibition of OPN expression; targeting downstream signaling pathways activated by OPN.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osteopontin (None).